[C0Q10 in the prevention and treatment of primary osteoporosis. Preliminary data].
Preliminary data are reported of an as yet uncompleted clinical study aimed at evaluating the therapeutic efficacy of C0Q10 for primary osteoporosis. In spite of the small number of subjects treated (only 5) the results obtained are evidence of the efficacy of this agent which had never before been used in the therapy of osteoporosis. The possible mechanisms of action C0Q10 are discussed in the light of an original interpretation of the etiopathogenesis of this very complex bone disease. Details of the study will be reported once the trial has been completed.
Neri Stagnaro
M
M
Laboratorio di Analisi, Ospedale di Lavagna, USL N. 4 Tigullo Orientale, Chiavari.
Stagnaro
S
S
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control*; D014451:Ubiquinone / Q000627:therapeutic use*
D014451:Ubiquinone; C025204:Ubiquinone Q2
Il C0Q10 nella prevenzione e nella terapia dell'osteoporosi primitiva. Dati preliminari.